APA (7th ed.) Citation

A, P., JS, P., Y, C., A, B., MP, S., M, B., . . . NM, A. (2023). Provider prescription of hydroxyurea in youth and adults with sickle cell disease: A review of prescription barriers and facilitators. British journal of haematology, 203(5), 712. https://doi.org/10.1111/bjh.19099

Chicago Style (17th ed.) Citation

A, Pizzo, et al. "Provider Prescription of Hydroxyurea in Youth and Adults with Sickle Cell Disease: A Review of Prescription Barriers and Facilitators." British Journal of Haematology 203, no. 5 (2023): 712. https://doi.org/10.1111/bjh.19099.

MLA (9th ed.) Citation

A, Pizzo, et al. "Provider Prescription of Hydroxyurea in Youth and Adults with Sickle Cell Disease: A Review of Prescription Barriers and Facilitators." British Journal of Haematology, vol. 203, no. 5, 2023, p. 712, https://doi.org/10.1111/bjh.19099.